Press Release | Newsroom | Medtronic | Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2016

Press Release

Printer Friendly Version View printer-friendly version
Download PDF Download PDF
<< Back
Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2016

Medtronic plc

DUBLIN - February 19, 2016 - Medtronic plc (NYSE: MDT) announced today it will report financial results for the third quarter of its fiscal year 2016 on Tuesday, March 1, 2016. A news release will be issued at approximately 5:45 a.m. Central Standard Time and will be available at The earnings news release will include summary financial information for the third fiscal quarter, which ended January 29, 2016.

Medtronic will host a webcast at 7:00 a.m. Central Standard Time to discuss financial results for the third quarter. The webcast can be accessed by clicking on the Investors link through the Medtronic website at on March 1, 2016.
Within 24 hours of the webcast, a replay and transcript of the prepared remarks will be available by clicking on the Investor Events link through the Investors section of the Medtronic website.

Looking ahead for the remainder of fiscal year 2016 and into fiscal year 2017, Medtronic plans to report financial results for its fourth quarter and fiscal year end on Tuesday, May 31, 2016. Medtronic also plans to host its biennial Institutional Investor & Analyst meeting on June 6, 2016.  Additional details will be provided closer to the event dates.

About Medtronic
Medtronic plc (, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 85,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.



Fernando Vivanco
Public Relations

Ryan Weispfenning
Investor Relations